The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Allscripts Healthcare Solutions Inc | COM | 01988P108 | 738 | 48,000 | SH | SOLE | 0 | 0 | 0 | ||
| Anika Therapeutics Inc | COM | 035255108 | 1,049 | 27,500 | SH | SOLE | 0 | 0 | 0 | ||
| Endologix Inc | COM | 29266S106 | 149 | 15,000 | SH | SOLE | 0 | 0 | 0 | ||
| Genomic Health Inc | COM | 37244C101 | 528 | 15,000 | SH | SOLE | 0 | 0 | 0 | ||
| Natera Inc | COM | 632307104 | 342 | 31,693 | SH | SOLE | 0 | 0 | 0 | ||
| T2 Biosystems Inc. Cmn | COM | 89853L104 | 229 | 20,900 | SH | SOLE | 0 | 0 | 0 | ||
| Veracyte Inc | COM | 92337F107 | 180 | 25,000 | SH | SOLE | 0 | 0 | 0 | ||
| Masimo Corp | COM | 574795100 | 1,075 | 25,900 | SH | SOLE | 0 | 0 | 0 | ||
| bluebird bio Inc | COM | 09609G100 | 340 | 5,300 | SH | SOLE | 0 | 0 | 0 | ||